Singula Bio is Biotechnology in United Kingdom that focus on operator business. Founded in 2020. They cover business area such as operator, a biotechnology firm, novel neoantigen-base cell therapy, cancer, immunological, medical, surgical and computational technology, selective therapy, difficult-to-treat solid malignancy, medical researcher, individualized cell therapy option, recurrence and prolong survival.
2020
( 4 years old in 2024 )
Operator
-
Weatherall Institute of Molecular Medicine
University of Oxford, John Radcliffe Hospital, Headington
Oxford OX3 9DS
England, United Kingdom
Private
operatora biotechnology firmnovel neoantigen-base cell therapycancerimmunological, medical, surgical and computational technologyselective therapydifficult-to-treat solid malignancymedical researcherindividualized cell therapy optionrecurrence and prolong survival
* We use standard office opening hours in near Singula Bio's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Singula Bio is Biotechnology business from United Kingdom that founded in 2020 (4 years old in 2024), Singula Bio business is focusing on Operator.
Singula Bio headquarter office and corporate office address is located in Weatherall Institute of Molecular Medicine University of Oxford, John Radcliffe Hospital, Headington Oxford OX3 9DS England, United Kingdom.
Singula Bio was founded in United Kingdom.
In 2024, Singula Bio is currently focus on operator sector.
Above is snippet of Google Trends for "operator" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Singula Bio, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
